Elite Pharmaceuticals (ELTP) Net Equity Issued and Repurchased (2011 - 2026)
Elite Pharmaceuticals' Net Equity Issued and Repurchased came in at $4,040 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 94.9% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Elite Pharmaceuticals reported Net Equity Issued and Repurchased of $172,793; for FY2026 (ended Mar 31, 2026), it was $318,753.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 49.8% (FY2021 to FY2026).
- Going back by fiscal year, Net Equity Issued and Repurchased was $19,305 in FY2025.
- The fiscal Q1 2027 figure represents the lowest quarterly Net Equity Issued and Repurchased in data going back to fiscal Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Elite Pharmaceuticals | 269.31 Mn | 150.98 Mn | 13.51 Mn | 4,040.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,040.00 |
| Mar 31, 2026 | 78,540.00 |
| Dec 31, 2025 | 90,213.00 |
| Mar 31, 2020 | 630,991.00 |
| Dec 31, 2019 | 83,100.00 |
| Sep 30, 2019 | 383,587.00 |
| Jun 30, 2019 | 340,300.00 |
| Mar 31, 2019 | 422,436.00 |
| Dec 31, 2018 | 273,549.00 |
| Sep 30, 2018 | 1.23 Mn |
| Jun 30, 2018 | 168,193.00 |
| Mar 31, 2018 | 963,513.00 |
| Dec 31, 2017 | 252,409.00 |
| Sep 30, 2017 | 531,920.00 |
| Jun 30, 2017 | 605,679.00 |
| Mar 31, 2017 | 1.82 Mn |
| Dec 31, 2016 | 1.82 Mn |
| Sep 30, 2016 | 2.63 Mn |
| Jun 30, 2016 | 3.18 Mn |
| Mar 31, 2016 | 3.50 Mn |
API Access
Elite Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();